Cellectis SA (CLLS)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 20, 16:00
1.58
-0.03
(-1.86%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly): 129.42M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Edap TMS SA | 47.63M |
| DBV Technologies SA | 54.03M |
| Genfit SA | 75.11M |
| Akari Therapeutics PLC | -6.694M |
| Biodexa Pharmaceuticals PLC | 11.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 395.88M |
| Total Liabilities (Quarterly) | 266.45M |
| Debt to Equity Ratio | 0.3579 |
| Current Ratio | 1.777 |
| Net Debt Paydown Yield | -1.21% |